Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Heron Therapeuti (HRTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Heron Therapeuti's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.800 +0.210    +8.11%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
2.800
0.000
0.000%
19:07:08 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 6,551,327
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.700 - 3.145
Heron Therapeuti 2.800 +0.210 +8.11%

Heron Therapeuti Company Profile

 
Get an in-depth profile of Heron Therapeuti, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

203

Equity Type

ORD

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.

Contact Information

Address 4242 Campus Point Court Suite 200
San Diego, 92121
United States
Phone 858 251 4400
Fax -

Top Executives

Name Age Since Title
Christian Waage 56 2016 Independent Director
Craig A. Johnson 61 2014 Lead Independent Director
Adam Morgan 44 2023 Independent Chairman
Craig Alexander Collard 57 2023 CEO & Director
Sharmila Dissanaike 49 2021 Independent Director
Susan Rodriguez 60 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HRTX Comments

Write your thoughts about Heron Therapeuti
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Max Mek
Max Mek Nov 19, 2021 10:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BEST BEAR PROMOTION!!!
Алексей Морма
Алексей Морма May 13, 2021 1:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
!!!! Heron's stock rises after FDA approval of surgical medicine
Joe Jordan
Joe Jordan Feb 20, 2021 2:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can this go back to 30 dollars?
Peter Merrill
PeterM Jan 08, 2018 5:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strong squeeze play candidate with prices consolidating and a recent pocket pivot. A lot of large players seem to be buying in. #Bullish
oguzhan ozturk
oguzhan ozturk Jan 08, 2018 5:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target price seems 32$ in 12 months? Do you agree?
Joel Hanson
Joel Hanson Nov 28, 2016 4:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$HRTX has all 9 analyst saying “BUY” with an ave 12 month target price of $37.33 which is 144% ROI at is closing price of $15.28
oguzhan ozturk
oguzhan ozturk Nov 28, 2016 4:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still sluggish
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email